Ludwig Edward J's Form 4 filing
Boston Scientific Corp (BSX) · filed Apr 29, 2024
- Accession no.
- 0001225208-24-005317
- Filed
- Apr 29, 2024
- Trade date
- Apr 26, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $719.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ludwig Edward JCIK 0001221783 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2024 | Common Stock | MOption exerciseAcquired | +9,818 | $17.37 | +$170,538.66 | 51,192 | Direct | |
| Apr 26, 2024 | Common Stock | SSaleDisposed | −9,818 | $73.29 | −$719,561.22 | 41,374 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2024 | Common Stock | MOption exerciseDisposed | −9,818 | $17.37 | −$170,538.66 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.